VERSATOPE THERAPEUTICS, INC.
Immuno-Therapeutics Through a Customized Biotechnology Platform
LOWELL, United States · Founded 2018
- Headquarters
- LOWELL, Massachusetts
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2G
- Website
- versatope.com
- Last Round
- GrantJan 2024
- Rounds
- 1
About
Versatope Therapeutics is a clinical-stage infectious disease company that uses synthetic biology to engineer recombinant nanovesicles derived from microbial membranes as a platform for targeted vaccine and immunotherapeutic delivery. The company's lead program, VT-105, is a universal influenza A vaccine candidate that has received IND allowance. Versatope's platform is also being applied to malaria vaccine development.
Summary
VERSATOPE THERAPEUTICS, INC. is a Biotech company based in LOWELL, United States, founded in 2018. Its most recent funding was a Grant round in Jan 2024. Investors include MassVentures.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...